scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1053124724 |
P356 | DOI | 10.1186/1471-2407-8-389 |
P932 | PMC publication ID | 2627917 |
P698 | PubMed publication ID | 19108738 |
P5875 | ResearchGate publication ID | 23698820 |
P50 | author | Jos Beijnen | Q23771643 |
Paul N Span | Q57165599 | ||
Elisabeth de Vries | Q64712784 | ||
Jan H M Schellens | Q89824209 | ||
Harm van Tinteren | Q92697862 | ||
Sjoerd Rodenhuis | Q116794231 | ||
P2093 | author name string | Nathan Harris | |
Jos W R Twisk | |||
Vivianne C G Tjan-Heijnen | |||
Marijke Bontenbal | |||
Marie-Christine W Gast | |||
Marianne A Nooij | |||
René Q G C M van Hoesel | |||
P2860 | cites work | Nucleotide sequence of the haptoglobin and haptoglobin-related gene pair. The haptoglobin-related gene contains a retrovirus-like element | Q24294714 |
Cancer statistics, 2008 | Q27860585 | ||
Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 | ||
A gene-expression signature as a predictor of survival in breast cancer | Q27860945 | ||
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer | Q29615523 | ||
Class prediction and discovery using gene microarray and proteomics mass spectroscopy data: curses, caveats, cautions | Q30817597 | ||
Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. | Q30975693 | ||
Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer. | Q31063929 | ||
HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples | Q33220604 | ||
Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy | Q33224014 | ||
Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors | Q33233612 | ||
Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer. | Q33234978 | ||
Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer | Q33288983 | ||
Biological functions of haptoglobin--new pieces to an old puzzle | Q33368325 | ||
Expression of haptoglobin-related protein and its potential role as a tumor antigen | Q33837149 | ||
Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis | Q33893185 | ||
Haptoglobin: function and polymorphism. | Q33927500 | ||
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer | Q33996115 | ||
Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer | Q35171086 | ||
Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the "do ut des" paradigm). | Q36442804 | ||
Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation | Q40244200 | ||
Biological and clinical significance of haptoglobin polymorphism in humans | Q41150251 | ||
High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer. | Q42163493 | ||
Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction | Q43622715 | ||
Bias as a threat to the validity of cancer molecular-marker research | Q44087175 | ||
Haptoglobin polymorphism and mortality in patients with tuberculosis. | Q44730475 | ||
Haptoglobin polymorphism, iron metabolism and mortality in HIV infection | Q47853455 | ||
Haptoglobin polymorphism in patients with preeclampsia | Q49078272 | ||
Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study. | Q52026600 | ||
Lessons from controversy: ovarian cancer screening and serum proteomics. | Q52973479 | ||
Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients. | Q54131719 | ||
Haptoglobin phenotype and diabetic nephropathy | Q56990252 | ||
Haptoglobin-related protein (Hpr) epitopes in breast cancer as a predictor of recurrence of the disease | Q69096330 | ||
Typing and subtyping of haptoglobin from native serum using disc gel electrophoresis in alkaline buffer: application to routine screening | Q70665067 | ||
Discovery-based research and fishing | Q73735534 | ||
Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group | Q77347398 | ||
Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients | Q79986560 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 389 | |
P577 | publication date | 2008-12-24 | |
P1433 | published in | BMC Cancer | Q326300 |
P1476 | title | Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients | |
P478 | volume | 8 |
Q51113485 | Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer. |
Q47813326 | Haptoglobin levels, but not Hp1-Hp2 polymorphism, are associated with polycystic ovary syndrome. |
Q35866409 | Identification of genes involved in breast cancer and breast cancer stem cells. |
Q33891208 | Identification of serum protein markers for breast cancer relapse with SELDI-TOF MS. |
Q35238008 | Mass spectrometry-based serum and plasma peptidome profiling for prediction of treatment outcome in patients with solid malignancies |
Q35637149 | Matrix-assisted laser desorption/ionisation (MALDI) TOF analysis identifies serum angiotensin II concentrations as a strong predictor of all-cause and breast cancer (BCa)-specific mortality following breast surgery |
Q34018095 | Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancer |
Q34319634 | Proteomic studies in breast cancer (Review). |
Q84779952 | Serum protein signature may improve detection of ductal carcinoma in situ of the breast |
Search more.